The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells

GLIA

Volumn 56, Issue 4, 2008, Pages 394-411

  Borán, Mariela Susana ^a   Baltrons, María Antonia ^a   García, Agustina ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Actin; Glia; NOS 2; Rho GTPases; TNF

Indexed keywords

ACTIN; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANOSINE TRIPHOSPHATASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROGLIA; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; BRAIN; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DIBUTYRYL CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN CULTURE TECHNIQUES; PHAGOCYTES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38949131925     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20618     Document Type: Article

References (71)

1. abd-el-Basset E, Fedoroff S. 1995. Effect of bacterial wall lipopolysaccharide (LPS) on morphology, motility, and cytoskeletal organization of microglia in cultures. J Neurosci Res 41:222-237.
2. Abraham H, Losonczy A, Czeh G, Lazar G. 2001. Rapid activation of microglial cells by hypoxia, kainic acid, and potassium ions in slice preparations of the rat hippocampus. Brain Res 906:115-126.
3. Aderem A, Underhill DM. 1999. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593-623.
4. Agullo L, Baltrons MA, Garcia A. 1995. Calcium-dependent nitric oxide formation in glial cells. Brain Res 686:160-168.
5. Allen WE, Jones GE, Pollard JW, Ridley AJ. 1997. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci 110(Part 6):707-720.
6. Aloisi F. 2001. Immune function of microglia. Glia 36:165-179.
7. Baltrons MA, Garcia A. 1999. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells. J Neurochem 73:2149-2157.
8. Baltrons MA, Saadoun S, Agullo L, Garcia A. 1997. Regulation by calcium of the nitric oxide/cyclic GMP system in cerebellar granule cells and astroglia in culture. J Neurosci Res 49:333-341.
9. Begum N, Sandu OA, Duddy N. 2002. Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: Role of nitric oxide and cyclic guanosine monophosphate signaling pathways. Diabetes 51:2256-2263.
10. Bohatschek M, Kloss CU, Kalla R, Raivich G. 2001. In vitro model of microglial deramification: Ramified microglia transform into amoeboid phagocytes following addition of brain cell membranes to microglia-astrocyte cocultures. J Neurosci Res 64:508-522.
11. Boran MS, Garcia A. 2007. The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes. J Neurochem 102:216-230.
12. Caron E, Hall A. 1998. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282:1717-1721.
13. Choi SH, Choi DH, Song KS, Shin KH, Chun BG. 2002. Zaprinast, an inhibitor of cGMP-selective phosphodiesterases, enhances the secretion of TNF-α and IL-1β and the expression of iNOS and MHC class II molecules in rat microglial cells. J Neurosci Res 67:411-421.
14. Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S. 1997. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med 186:1487-1494.
15. de Vente J, Bol JG, Steinbusch HW. 1989. Localization of cGMP in the cerebellum of the adult rat: An immunohistochemical study. Brain Res 504:332-337.
16. de Vente J, Steinbusch H. 2000. Nitric oxide-cGMP signalling in the rat brain. In: Steinbusch H, de Vente J, Vicent S, editors. Funcional neuroanatomy of the nitric oxide system. Handbook of chemical neuroanatomy. Amsterdam: Elservier. pp 355-415.
17. Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL. 2004. Inhibition of microglial inflammatory responses by norepinephrine: Effects on nitric oxide and interleukin-1β production. J Neuroinflammation 1:9.
18. Diaz-Cazorla M, Perez-Sala D, Lamas S. 1999. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J Am Soc Nephrol 10:943-952.
19. Erwig LP, Henson PM. 2007. Clearance of apoptotic cells by phagocytes. Cell Death Differ. In press. Epub ahead of print (doi:10.1038/sj.ccd.4402184).
20. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
21. Feinstein DL, Heneka MT, Gavrilyuk V, Dello Russo C, Weinberg G, Galea E. 2002. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int 41:357-365.
22. Fryer BH, Wang C, Vedantam S, Zhou GL, Jin S, Fletcher L, Simon MC, Field J. 2006. cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilator-stimulated phosphoprotein association. J Biol Chem 281:11487-11495.
23. Furst R, Brueckl C, Kuebler WM, Zahler S, Krotz F, Gorlach A, Vollmar AM, Kiemer AK. 2005. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96:43-53.
24. Galea E, Feinstein DL, Reis DJ. 1992. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA 89:10945-10949.
25. Ghafouri M, Amini S, Khalili K, Sawaya BE. 2006. HIV-1 associated dementia: Symptoms and causes. Retrovirology 3:28.
26. Gonzalez-Scarano F, Baltuch G. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-240.
27. Gudi T, Chen JC, Casteel DE, Seasholtz TM, Boss GR, Pilz RB. 2002. cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions. J Biol Chem 277:37382-37393.
28. Hackam DJ, Rotstein OD, Schreiber A, Zhang W, Grinstein S. 1997. Rho is required for the initiation of calcium signaling and phagocytosis by Fc-γ receptors in macrophages. J Exp Med 186:955-966.
29. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
30. Howard TH, Oresajo CO. 1985. A method for quantifying F-actin in chemotactic peptide activated neutrophils: Study of the effect of tBOC peptide. Cell Motil 5:545-557.
31. Kalla R, Bohatschek M, Kloss CU, Krol J, Von Maltzan X, Raivich G. 2003. Loss of microglial ramification in microglia-astrocyte cocultures: Involvement of adenylate cyclase, calcium, phosphatase, and Gi-protein systems. Glia 41:50-63.
32. Ke X, Terashima M, Nariai Y, Nakashima Y, Nabika T, Tanigawa Y. 2001. Nitric oxide regulates actin reorganization through cGMP and Ca(2+)/calmodulin in RAW 264.7 cells. Biochim Biophys Acta 1539:101-113.
33. Kiemer AK, Vollmar AM. 1998. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 273:13444-13451.
34. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81:302-313.
35. Kim YS, Joh TH. 2006. Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 38:333-347.
36. Kloss CU, Bohatschek M, Kreutzberg GW, Raivich G. 2001. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol 168:32-46.
37. Krepinsky JC, Ingram AJ, Tang D, Wu D, Liu L, Scholey JW. 2003. Nitric oxide inhibits stretch-induced MAPK activation in mesangial cells through RhoA inactivation. J Am Soc Nephrol 14:2790-2800.
38. Krzan M, Stenovec M, Kreft M, Pangrsic T, Grilc S, Haydon PG, Zorec R. 2003. Calcium-dependent exocytosis of atrial natriuretic peptide from astrocytes. J Neurosci 23:1580-1583.
39. Leverrier Y, Ridley AJ. 2001. Requirement for Rho GTPases and PI 3-kinases during apoptotic cell phagocytosis by macrophages. Curr Biol 11:195-199.
40. Mackay DJ, Hall A. 1998. Rho GTPases. J Biol Chem 273:20685-20688.
41. Massol P, Montcourrier P, Guillemot JC, Chavrier P. 1998. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J 17:6219-6229.
42. Minghetti L, Ajmone-Cat MA, De Berardinis MA, De Simone R. 2005. Microglial activation in chronic neurodegenerative diseases: Roles of apoptotic neurons and chronic stimulation. Brain Res Brain Res Rev 48:251-256.
43. Moriyama N, Taniguchi M, Miyano K, Miyoshi M, Watanabe T. 2006. ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-κB and AP-1 activations. Biochem Biophys Res Commun 350:322-328.
44. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
45. Nogami M, Shiga J, Takatsu A, Endo N, Ishiyama I. 2001. Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem J 33:87-90.
46. Paris D, Town T, Mullan M. 2000. Novel strategies for opposing murine microglial activation. Neurosci Lett 278:5-8.
47. Paris D, Town T, Parker TA, Tan J, Humphrey J, Crawford F, Mullan M. 1999. Inhibition of Alzheimer's β-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism. Exp Neurol 157:211-221.
48. Perez-Sala D, Cernuda-Morollon E, Diaz-Cazorla M, Rodriguez-Pascual F, Lamas S. 2001. Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol Renal Physiol 280:F466-F473.
49. Pilz RB, Broderick KE. 2005. Role of cyclic GMP in gene regulation. Front Biosci 10:1239-1268.
50. Potucek YD, Crain JM, Watters JJ. 2006. Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem Int 49:204-214.
51. Raivich G, Jones LL, Werner A, Bluthmann H, Doetschmann T, Kreutzberg GW. 1999. Molecular signals for glial activation: Pro- and anti-inflammatory cytokines in the injured brain. Acta Neurochir Suppl 73:21-30.
52. Roy A, Fung YK, Liu X, Pahan K. 2006. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 281:14971-14980.
53. Sandu OA, Ito M, Begum N. 2001. Selected contribution: Insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle. J Appl Physiol 91:1475-1482.
54. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
55. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G. 2000. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275:21722-21729.
56. Sauzeau V, Rolli-Derkinderen M, Marionneau C, Loirand G, Pacaud P. 2003. RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J Biol Chem 278:9472-9480.
57. Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, Yurugi T, Nakao K. 2001. cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 280:798-805.
58. Sola C, Casal C, Tusell JM, Serratosa J. 2002. Astrocytes enhance lipopolysaccharide-induced nitric oxide production by microglial cells. Eur J Neurosci 16:1275-1283.
59. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
60. Streit WJ. 2005. Microglia and neuroprotection: Implications for Alzheimer's disease. Brain Res Brain Res Rev 48:234-239.
61. Streit WJ, Kreutzberg GW. 1988. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248-263.
62. Teunissen CE, Steinbusch HW, Markerink-van Ittersum M, De Bruijn C, Axer H, De Vente J. 2000. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction. Brain Res Dev Brain Res 125:99-115.
63. Tosello-Trampont AC, Nakada-Tsukui K, Ravichandran KS. 2003. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J Biol Chem 278:49911-49919.
64. Town T, Nikolic V, Tan J. 2005. The microglial "activation" continuum: From innate to adaptive responses. J Neuroinflammation 2:24.
65. Townsend KP, Town T, Mori T, Lue LF, Shytle D, Sanberg PR, Morgan D, Fernandez F, Flavell RA, Tan J. 2005. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β-peptide. Eur J Immunol 35:901-910.
66. van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, Behrends S, de Vente J. 2004. Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry. Eur J Neurosci 19:2155-2168.
67. Vollmar AM. 2005. The role of atrial natriuretic peptide in the immune system. Peptides 26:1086-1094.
68. Vollmar AM, Forster R, Schulz R. 1997. Effects of atrial natriuretic peptide on phagocytosis and respiratory burst in murine macrophages. Eur J Pharmacol 319:279-285.
69. Wiggins AK, Shen PJ, Gundlach AL. 2003. Atrial natriuretic peptide expression is increased in rat cerebral cortex following spreading depression: Possible contribution to sd-induced neuroprotection. Neuroscience 118:715-726.
70. Wyss-Coray T. 2006. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med 12:1005-1015.
71. Zamir N, Skofitsch G, Eskay RL, Jacobowitz DM. 1986. Distribution of immunoreactive atrial natriuretic peptides in the central nervous system of the rat. Brain Res 365:105-111.